News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck KGaA (MKGAF.PK) Has Cash Ready To Pursue A Takeover Worth Billions: CEO



2/21/2014 7:28:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Diversified drugs and chemicals group Merck KGaA is ready to pursue a takeover worth billions to boost its medicines unit even after making an offer for AZ Electronic Materials, its chief executive told a German newspaper. "We can easily invest a high single-digit billion amount, without endangering our good rating," CEO Karl-Ludwig Kley was quoted as saying by daily Handelsblatt. Standard & Poor's has a long-term issuer rating 'A' with a stable outlook on Merck.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES